Biotech Values

[RockRat]

Any thoughts on Squarer & Holden? The BOD appointments look OK. Nereus, Dr. Holden's employer for the past 7 years appears to be dying a quiet death w/o getting anything beyond P2. Last clinical trial update, a completed P2 over a year ago. No PR in almost two years. Prior to that, they'd kick out 2 or 3 PRs per year. Makes me wonder about Holden's effectiveness these days. Or maybe he just hired into a company that turned out to have loser compounds, and there was nothing he could have done about it.

Has Squarer ever led anything resembling a development stage research boutique? Hospira and Array aren't too similar, and they're awfully vague about his prior career posts.

Regards, RockRat